Masaaki Kawai
Yamagata, 9909575, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Genomic Landscape and Therapeutic Implications of Metaplastic Breast Carcinoma: Insights from a Nationwide Database Including Diagnostic Mimickers.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 18, 2026
Real-world outcomes of anthracycline and taxane-based perioperative breast cancer therapy using the Japanese electronic medical record database.
Journal: Japanese journal of clinical oncology
Published: August 02, 2025
Effusion Reduction after Early Trastuzumab Deruxtecan Therapy for Unresectable HER2-Low Breast Cancer in an Older Patient: A Case Report.
Journal: Surgical case reports
Published: July 30, 2025
Clinical Characteristics and Chemosensitivity in Germline TP53 Pathogenic Variant Cases Identified by Cancer Genomic Testing.
Journal: Cancer genomics & proteomics
Published: November 18, 2024
Investigation of tumor mutation burden using the comprehensive genomic profiling data of vulvar and vaginal malignant tumors: an observational study using C-CAT database.
Journal: International journal of clinical oncology
Published: September 28, 2024
Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.
Journal: Breast cancer (Tokyo, Japan)
Published: May 12, 2024
TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohorts.
Journal: Translational oncology
Published: May 04, 2024
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.
Journal: Breast cancer (Tokyo, Japan)
Published: February 07, 2024
Real-World Patient Characteristics, Treatment Patterns, and Outcomes of HR+, HER2- Early Breast Cancer Patients in Japan: An Analysis with National Database(NDB).
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 22, 2024
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition.
Journal: Breast cancer (Tokyo, Japan)
Published: September 29, 2023
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
Journal: Journal of Cancer
Published: June 14, 2023
Last Updated: 09/26/2026